These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17242153)

  • 1. Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis.
    Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1537-40. PubMed ID: 17242153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.
    Wayne LG; Sramek HA
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2054-8. PubMed ID: 7811018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH.
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
    Paramasivan CN; Sulochana S; Kubendiran G; Venkatesan P; Mitchison DA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):627-31. PubMed ID: 15673743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a rapid method for detection of M. tuberculosis resistance to INH and RMP in Lima, Peru.
    De Kantor IN
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):707; author reply 707-8. PubMed ID: 16776461
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of drug combinations against dormant Mycobacterium tuberculosis.
    Filippini P; Iona E; Piccaro G; Peyron P; Neyrolles O; Fattorini L
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2712-5. PubMed ID: 20350948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 8. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
    Hu Y; Coates AR; Mitchison DA
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens.
    Bang D; Bengård Andersen A; Thomsen VØ
    J Clin Microbiol; 2006 Jul; 44(7):2605-8. PubMed ID: 16825393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 12. Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis.
    Hoff DR; Caraway ML; Brooks EJ; Driver ER; Ryan GJ; Peloquin CA; Orme IM; Basaraba RJ; Lenaerts AJ
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4137-40. PubMed ID: 18694944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR.
    Kocagoz T; Saribas Z; Alp A
    J Clin Microbiol; 2005 Dec; 43(12):6015-9. PubMed ID: 16333091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 16. [Growth of rifampin-dependent Mycobacterium tuberculosis in conditions without rifampin].
    Zhong M; Wang Y; Sun C; Yin H; Wang A; Zhong M; Lou L
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Oct; 25(10):588-90. PubMed ID: 12490123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dormant tubercle bacilli: the key to more effective TB chemotherapy?
    Dick T
    J Antimicrob Chemother; 2001 Jan; 47(1):117-8. PubMed ID: 11152444
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Kaushik A; Makkar N; Pandey P; Parrish N; Singh U; Lamichhane G
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6561-7. PubMed ID: 26259792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain.
    González N; Torres MJ; Aznar J; Palomares JC
    Tuber Lung Dis; 1999; 79(3):187-90. PubMed ID: 10656117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.